WASHINGTON – Today, the House of Representatives voted 230-192 to pass H.R. 3, The Lower Drug Costs Now Act of 2019. This bill is the culmination of months of work by members of the House to keep the promises they made to fight back against the pharmaceutical industry and reduce the costs of prescription drugs for patients and families.
“With today’s vote, 192 members of the House of Representatives sent a clear signal to their constituents that they would rather stand with Big Pharma than with the patients and families they are supposed to represent,” said Lizzy Price, director of Restore Public Trust.
“Big Pharma has spent hundreds of millions of dollars on lobbyists to try to block this bill and any meaningful action to reduce the cost of prescription drugs for patients, and that investment paid off with 192 members today.
“Now that this strong bill has passed the House, the onus is on the Senate and the Trump Administration to push aside Big Pharma and do the right thing for patients and families. People across the country will be watching to see if their elected officials put Big Pharma profits ahead of patients and prevent this bill from becoming law.”
The Lower Drug Costs Now Act of 2019 would reduce the cost of prescription drugs for patients and families by giving the health secretary the power to negotiate with drug companies, preventing drug companies from ripping off Americans with higher prices than those they charge to patients in other countries, limiting out of pocket costs for seniors, investing taxpayer savings into research and innovation, and more.